WebJan 16, 2024 · In September 2024, Citius Pharmaceuticals had US$42m in cash, and was debt-free. Importantly, its cash burn was US$28m over the trailing twelve months. Therefore, from September 2024 it had... WebAug 3, 2024 · EX-4.1 3 ctxr_ex41.htm WARRANT AGENT AGREEMENT ctxr_ex41.htm. EXHIBIT 4.1 . WARRANT AGENT AGREEMENT . WARRANT AGENT AGREEMENT (this “Warrant Agreement”) dated as of August 3, 2024 (the “Issuance Date”) between Citius Pharmaceuticals, Inc., a company incorporated under the laws of the State of Nevada …
CitiBusiness® Online - Citigroup
WebPR Newswire +10.26%. Citius Pharmaceuticals, Inc., a late-stage pharmaceutical company, engages in the development and commercialization of critical care products focusing on oncology products, anti-infectives products in adjunct cancer care, prescription products, and stem cell therapy. It is developing five proprietary products comprising I ... Web·Graduado en ADE (CUNEF) 2024 ·Master Gestión empresarial y marketing farmacéutico CITIUS (UAM) 2024 En búsqueda activa de empleo, con completa disponibilidad Especializado en el sector farmacéutico. Obtén más información sobre la experiencia laboral, la educación, los contactos y otra información … chrome pc antigo
Warrant Agent Agreement dated August 3, 2024 between Citius Citius …
WebFeb 10, 2024 · Citius is a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, unique … WebAbout us. We are Citius Partners – a revenue growth consultancy. We partner with growth, private equity, and venture capital funds to help their B2B technology portfolio … WebApr 4, 2024 · In a report released yesterday, Michael Okunewitch from Maxim Group maintained a Buy rating on Citius Pharmaceuticals (CTXR – Research Report), with a … chrome pdf 转 图片